What Does Suboxone Show on a Drug Test?

Discover exactly what Suboxone shows on a drug test today. Learn about buprenorphine detection, false positives, and panel specifics for employers and clinics.

Suboxone (buprenorphine/naloxone) shows on a drug test only if the test specifically includes a buprenorphine panel. Standard 5-panel and 10-panel urine drug screens do not detect Suboxone metabolites. However, expanded panels, confirmatory GC/MS tests, and certain clinic-specific cups will flag buprenorphine as a separate analyte. Today, with updated SAMHSA guidelines and the rise of fentanyl-adulterated street opioids, more employers and treatment programs are adding buprenorphine to their testing profiles to monitor MAT compliance and diversion. This guide explains exactly when and how Suboxone appears, how long it stays detectable, and what to expect if you are prescribed it.

How Suboxone Is Detected on Drug Tests

Suboxone contains two active ingredients: buprenorphine (a partial opioid agonist) and naloxone (an opioid antagonist added to deter injection abuse). Drug tests look for buprenorphine or its primary metabolite, norbuprenorphine. Naloxone is rarely tested for because it is short-lived and not a target for abuse monitoring.

Standard vs. Expanded Drug Panels

Most common drug tests in the US—employer pre-employment, DOT, and routine urinalysis—use a 5-panel (amphetamines, cocaine, marijuana, opiates, PCP) or a 10-panel (adds barbiturates, benzodiazepines, methadone, propoxyphene, and quaaludes). Suboxone does not trigger a positive on any of these standard panels. Opiate screens typically target morphine and codeine; buprenorphine is structurally different and requires its own immunoassay.

  • 5-panel: No Suboxone detection.
  • 10-panel: No Suboxone detection.
  • Expanded 12- or 14-panel: Often includes buprenorphine as a separate line.
  • Clinic MAT panels: Always include buprenorphine to confirm patient adherence.
  • GC/MS confirmation: Identifies buprenorphine and norbuprenorphine with high specificity.

Detection Windows for Suboxone

Buprenorphine is lipophilic and has a long half-life (24–60 hours). Detection times depend on dose, frequency, metabolism, and test type.

Test TypeDetection Window (Approximate)
Urine (standard immunoassay)2–4 days after last dose
Urine (GC/MS confirmation)Up to 7–10 days in chronic users
Blood24–48 hours
Saliva1–3 days
Hair follicleUp to 90 days (rarely used for buprenorphine)

Note: Sublingual film and tablet formulations have slightly different absorption rates, but the detection window remains similar. Hydration, liver function, and body fat can alter these ranges.

Can Suboxone Cause a False Positive?

False positives for buprenorphine are uncommon but possible if the immunoassay cross-reacts with other substances. Known interferents include high doses of tramadol, certain antihistamines (doxylamine), and some antidepressants (e.g., sertraline). However, modern current tests use monoclonal antibodies that are highly specific. If a false positive is suspected, a GC/MS confirmation will rule it out definitively. Conversely, Suboxone will not cause a false positive for morphine, heroin, or oxycodone—those are separate assays.

Suboxone and Opiate Screening

Because buprenorphine is a partial opioid agonist, some older opiate immunoassays (targeting morphine) may show a faint cross-reactivity at very high concentrations, but this is rare and typically only at >50,000 ng/mL. In practice, a standard opiate screen is negative for Suboxone users. This is why treatment programs order a specific buprenorphine test.

Why Employers and Clinics Test for Suboxone today

With the ongoing opioid crisis and increased access to MAT (Medication-Assisted Treatment), many employers now include buprenorphine in their drug panels to ensure safety-sensitive positions (e.g., trucking, healthcare, heavy machinery) are not impaired. Suboxone can cause sedation, dizziness, and cognitive slowing, especially during dose titration. Additionally, addiction treatment centers use buprenorphine testing to verify that patients are taking their medication as prescribed and not diverting it to the black market.

What to Do If You Are Prescribed Suboxone and Need a Drug Test

If you have a valid prescription for Suboxone, disclose it to the testing facility or employer’s medical review officer (MRO) before the test. Provide your prescription bottle or pharmacy record. The MRO will verify the prescription and report the result as negative for illicit drugs but positive for buprenorphine as prescribed. Failure to disclose a legal prescription can lead to a false positive for a “non-prescribed opioid” and potential disciplinary action.

For employers: consider adding a buprenorphine-specific line to your panel if you hire MAT patients. For patients: carry documentation of your prescription at all times if you work in a safety-sensitive role.

Get the Right Test for Suboxone Detection

Need to verify Suboxone use for compliance, treatment monitoring, or workplace screening? DrugPanels.com offers CLIA-waived urine cups that include buprenorphine as a standalone analyte, as well as lab-based GC/MS confirmation kits. All tests are FDA-cleared and compliant with SAMHSA standards. Order your buprenorphine drug test panel here and receive fast, discreet shipping to your clinic or home.

Need a drug test near you?

Certified labs, clear pricing, fast results.

Find a Drug Test Near You

Frequently asked questions

Does Suboxone show up on a standard 5-panel drug test?

No. Standard 5-panel tests screen for amphetamines, cocaine, marijuana, opiates (morphine/codeine), and PCP. Suboxone's buprenorphine is not detected unless a specific buprenorphine panel is included.

Can Suboxone cause a false positive for opiates?

It is extremely rare. Most modern opiate immunoassays do not cross-react with buprenorphine at therapeutic levels. A GC/MS confirmation will definitively distinguish Suboxone from other opioids.

How long does Suboxone stay in your urine?

Buprenorphine is detectable in urine for 2–4 days after the last dose via standard immunoassay, and up to 7–10 days with GC/MS confirmation in chronic users.

Will Suboxone show up on a DOT drug test?

The standard DOT 5-panel does not include buprenorphine. However, DOT allows employers to add additional substances for safety-sensitive positions, so a buprenorphine-specific test may be added.

What if I have a prescription for Suboxone and test positive?

Disclose your prescription to the Medical Review Officer (MRO) before the test. The MRO will verify the prescription and report the result as negative for illicit substances, with buprenorphine noted as prescribed.

Medical disclaimer: This guide is for general education only and is not medical or legal advice. Drug testing procedures and cutoff levels vary by laboratory and employer. Always follow the instructions of the testing facility and consult a qualified professional about your results.

Affiliate disclosure: DrugPanels may earn a commission when you book a test through links on this page, at no extra cost to you.

← All guides